Xeltis Hemodialysis Access (aXess) Conduit: aXess-E Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Xeltis Hemodialysis Access (aXess) Conduit: aXess-E Study — Stella

Recruiting

Back to End Stage Renal Disease trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

Portugal

Hospital de Santa Maria, Lisbon

Serbia

Kliničko bolnički centar Zvezdara Klinika za Interne Bolesti, Belgrade

Key details

Sponsor

Xeltis

Enrollment target

~20 participants

Started

December 2024

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov